MNK1 inhibitor as an antiviral agent suppresses buffalopox virus protein synthesis
- PMID: 30393013
- DOI: 10.1016/j.antiviral.2018.10.022
MNK1 inhibitor as an antiviral agent suppresses buffalopox virus protein synthesis
Abstract
A small molecule chemical inhibitor CGP57380 that blocks activation of MAPK interacting kinase 1 (MNK1) was found to significantly suppress buffalopox virus (BPXV) replication. BPXV infection was shown to induce MNK1 activation. Depletion of MNK1 by small interfering RNA (siRNA), blocking activation of extracellular regulated kinase (ERK, an upstream activator of MNK1) and disruption of eIF4E/eIF4G interaction (downstream substrate of MNK1 which plays a central role in cap-dependent translation initiation), resulted in reduced BPXV replication, suggesting that ERK/MNK1/eIF4E signaling is a prerequisite for BPXV replication. With the help of time-of-addition and virus step-specific assays, CGP57380 treatment was shown to decrease synthesis of viral genome (DNA). Disruption of ERK/MNK1/eIF4E signaling resulted in reduced synthesis of viral proteins, suggesting that BPXV utilizes cap-dependent mechanism of translation initiation. Therefore, we concluded that decreased synthesis of viral genome in presence of MNK1 inhibitor is the result of reduced synthesis of viral proteins. Furthermore, BPXV was sequentially passaged (P = 40) in presence of CGP57380 or vehicle control (DMSO). As compared to P0 and P40-control viruses, P40-CGP57380 virus replicated at significantly higher (∼10-fold) titers in presence of CGP57380, although a complete resistance could not be achieved. In a BPXV egg infection model, CGP57380 was found to prevent development of pock lesions on chorioallantoic membrane (CAM) as well as associated mortality of the embryonated chicken eggs. We for the first time demonstrated in vitro and in ovo antiviral efficacy of CGP57380 against BPXV and identified that ERK/MNK1 signaling is a prerequisite for synthesis of viral proteins. Our study also describes a rare report about generation of drug-resistant viral variants against a host-targeting antiviral agent.
Keywords: Antiviral efficacy; CGP57380; Drug resistance; MNK1; Protein synthesis.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants.Antiviral Res. 2017 Aug;144:196-204. doi: 10.1016/j.antiviral.2017.06.006. Epub 2017 Jun 15. Antiviral Res. 2017. PMID: 28624461
-
Hesperetin blocks poxvirus replication with a low tendency to select for drug-resistant viral variants.J Med Virol. 2024 Apr;96(4):e29555. doi: 10.1002/jmv.29555. J Med Virol. 2024. PMID: 38546037
-
MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells.Acta Pharmacol Sin. 2018 Dec;39(12):1894-1901. doi: 10.1038/s41401-018-0161-0. Epub 2018 Oct 8. Acta Pharmacol Sin. 2018. PMID: 30297804 Free PMC article.
-
Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors.Curr Med Chem. 2017;24(28):3025-3053. doi: 10.2174/0929867324666170203123427. Curr Med Chem. 2017. PMID: 28164761 Review.
-
Role of MAPK/MNK1 signaling in virus replication.Virus Res. 2018 Jul 15;253:48-61. doi: 10.1016/j.virusres.2018.05.028. Epub 2018 Jun 1. Virus Res. 2018. PMID: 29864503 Free PMC article. Review.
Cited by
-
Studies on Growth Characteristics and Cross-Neutralization of Wild-Type and Delta SARS-CoV-2 From Hisar (India).Front Cell Infect Microbiol. 2021 Nov 23;11:771524. doi: 10.3389/fcimb.2021.771524. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34888260 Free PMC article.
-
Pathogenicity and virulence of lumpy skin disease virus: A comprehensive update.Virulence. 2025 Dec;16(1):2495108. doi: 10.1080/21505594.2025.2495108. Epub 2025 Apr 27. Virulence. 2025. PMID: 40265421 Free PMC article. Review.
-
Isolation and characterization of bovine herpes virus 5 (BoHV5) from cattle in India.PLoS One. 2020 Apr 24;15(4):e0232093. doi: 10.1371/journal.pone.0232093. eCollection 2020. PLoS One. 2020. PMID: 32330151 Free PMC article.
-
Host-Directed Antiviral Therapy.Clin Microbiol Rev. 2020 May 13;33(3):e00168-19. doi: 10.1128/CMR.00168-19. Print 2020 Jun 17. Clin Microbiol Rev. 2020. PMID: 32404434 Free PMC article. Review.
-
p38-MAPK is prerequisite for the synthesis of SARS-CoV-2 protein.Virusdisease. 2024 Jun;35(2):329-337. doi: 10.1007/s13337-024-00873-y. Epub 2024 May 27. Virusdisease. 2024. PMID: 39071879 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous